Publications by authors named "Ricardo Alvim"

Claim this Profile
S
Synergistic Efficacy of WST11-VTP and P-Selectin-Targeted Nanotherapy in a Preclinical Prostate Cancer Model.
Lucas Nogueira, Ricardo Alvim, Hanan Baker, Karan Nagar, Jasmine Thomas, Laura Alvim

Cancers (Basel)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in the Perioperative Management and Outcomes of Patients With Upper Tract Urothelial Carcinoma Undergoing Radical Nephroureterectomy at Memorial Sloan Kettering Cancer Center: Over 20 Years of Experience.
Wesley Yip, Melissa J Assel, Nathan C Wong, Andrew T Tracey, Ricardo G Alvim

Urol Pract· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Final Results of a Phase I Trial of WST-11 (TOOKAD Soluble) Vascular-targeted Photodynamic Therapy for Upper Tract Urothelial Carcinoma.
Wesley Yip, Daniel D Sjoberg, Lucas M Nogueira, Andrew T Tracey, Ricardo G Alvim

J Urol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter Phase II Clinical Trial of Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy for Patients With High-Grade Upper Tract Urothelial Carcinoma.
Jonathan A Coleman, Wesley Yip, Nathan C Wong, Daniel D Sjoberg, Bernard H Bochner, Ricardo G Alvim

J Clin Oncol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncologic outcomes of patients with lymph node invasion at prostatectomy and post-prostatectomy biochemical persistence.
Marlon Perera, Souhil Lebdai, Amy L Tin, Daniel D Sjoberg, Nicole Benfante, Ricardo G Alvim

Urol Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival Impact of Variant Histology Diagnosis in Upper Tract Urothelial Carcinoma.
Lucas M Nogueira, Wesley Yip, Melissa J Assel, Andrew T Tracey, Nathan C Wong, Ricardo G Alvim

J Urol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Morbidity of salvage radical prostatectomy: limited impact of the minimally invasive approach.
Marlon Perera, Antoni Vilaseca, Amy L Tin, Daniel P Nguyen, Renato B Corradi, Ricardo Alvim

World J Urol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional and Oncological Outcomes of Renal Surgery for Hilar Tumors: Informing the Decisions in Risk-Adapted Management.
Ricardo G Alvim, Amy L Tin, Lucas Nogueira, Nathan C Wong, Renato C Fonseca

Urology· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Focal therapy for primary and salvage prostate cancer treatment: a narrative review.
Andrew T Tracey, Lucas M Nogueira, Ricardo G Alvim, Jonathan A Coleman, Katie S Murray

Transl Androl Urol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined OX40 Agonist and PD-1 Inhibitor Immunotherapy Improves the Efficacy of Vascular Targeted Photodynamic Therapy in a Urothelial Tumor Model.
Ricardo G Alvim, Petrina Georgala, Lucas Nogueira, Alexander J Somma, Karan Nagar, Laura Alvim

Molecules· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparison of oncologic and functional outcomes in patients with pt3a renal cell carcinoma treated with partial and radical nephrectomy.
Ricardo Alvim, Amy Tin, Lucas Nogueira, Souhil Lebdai, Nathan Wong

Int Braz J Urol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Positron Emission Tomography/Computed Tomography with Gallium-68-labeled Prostate-specific Membrane Antigen Detects Relapse After Vascular-targeted Photodynamic Therapy in a Prostate Cancer Model.
Ricardo Alvim, Karan Nagar, Sudeep Das, Souhil Lebdai, Nathan Wong

Eur Urol Focus· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant vascular-targeted photodynamic therapy improves survival and reduces recurrence and progression in a mouse model of urothelial cancer.
Barak Rosenzweig, Renato B Corradi, Sadna Budhu, Ricardo Alvim, Pedro Recabal

Sci Rep· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extranodal NK/T-cell lymphoma, nasal type with extensive cardiopulmonary involvement.
Mario L Marques-Piubelli, Gabriel Teixeira Montezuma Sales, Letícia Campos Clemente, Lidiane Inês Rosa, Mariana Lorenzi Savioli, Ricardo Pires Alvim

Autops Case Rep· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply by Authors.
Sigrid Carlsson, Nicole Benfante, Ricardo Alvim, Daniel D Sjoberg, Andrew Vickers

J Urol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rasmussen encephalitis: an older adult presentation?
Ricardo Pires Alvim, Patrick Aguiar, Daniel Kempel Amado, Maria Sheila Guimarães Rocha, Roberta Diehl Rodriguez

Dement Neuropsychol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developments in Vascular-Targeted Photodynamic Therapy for Urologic Malignancies.
Lucas Nogueira, Andrew T Tracey, Ricardo Alvim, Peter Reisz, Avigdor Scherz

Molecules· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second-Generation RT-QuIC Assay for the Diagnosis of Creutzfeldt-Jakob Disease Patients in Brazil.
Breno José Alencar Pires Barbosa, Bruno Batitucci Castrillo, Ricardo Pires Alvim, Marcelo Houat de Brito, Helio R Gomes

Front Bioeng Biotechnol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Outcomes of Active Surveillance for Prostate Cancer: The Memorial Sloan Kettering Cancer Center Experience.
Sigrid Carlsson, Nicole Benfante, Ricardo Alvim, Daniel D Sjoberg, Andrew Vickers

J Urol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of Metastasis in Men with Grade Group 2 Prostate Cancer Managed with Active Surveillance at a Tertiary Cancer Center.
Sigrid Carlsson, Nicole Benfante, Ricardo Alvim, Daniel D Sjoberg, Andrew Vickers

J Urol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply by Authors.
Sigrid Carlsson, Nicole Benfante, Ricardo Alvim, Daniel D Sjoberg, Andrew Vickers

J Urol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling biological and genetic diversity in upper tract urothelial carcinoma with patient derived xenografts.
Kwanghee Kim, Wenhuo Hu, François Audenet, Nima Almassi, Aphrothiti J Hanrahan, Ricardo Alvim

Nat Commun· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extensive disease among potential candidates for hemi-ablative focal therapy for prostate cancer.
Toshikazu Takeda, Amy L Tin, Renato B Corradi, Ricardo Alvim, Takeshi Hashimoto

Int J Urol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunoengineering in glioblastoma imaging and therapy.
Steven Zanganeh, Petrina Georgala, Claudia Corbo, Leila Arabi, Jim Q Ho, Ricardo Alvim

Wiley Interdiscip Rev Nanomed Nanobiotechnol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance Prediction for Surgical Outcomes in Partial Nephrectomy Using Nephrometry Scores: A Comparison of Arterial Based Complexity (ABC), RENAL, and PADUA Systems.
Ricardo G Alvim, François Audenet, Emily A Vertosick, Daniel D Sjoberg, Karim A Touijer

Eur Urol Oncol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis